Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

King, J&J Won't Need to Register Users of Painkillers, U.S. Regulators Say
Bloomberg
Tuesday, June 29, 2010 - 11:34am
tags:
King, JNJ, painkillers, FDA
Hospira to close $145M Javelin deal this week
Yahoo/AP
Tuesday, June 29, 2010 - 11:32am
tags:
Hospira, Javelin, M&A
Bayer withdraws patent suit against Teva-documents
Reuters
Tuesday, June 29, 2010 - 10:22am
tags:
patents, Bayer, Yaz, Teva Pharmaceuticals, birth control pill, generics
AstraZeneca’s Crestor Trial May Have Been Biased, Report Says
Bloomberg Businessweek
Tuesday, June 29, 2010 - 10:20am
tags:
AstraZeneca, Crestor
What One Doctor And Staff Want For Lunch
Pharmalot
Tuesday, June 29, 2010 - 9:52am
tags:
physicians
Chelsea Therapeutics says it will submit new rheumatoid arthritis drug data to FDA in July
Yahoo/AP
Tuesday, June 29, 2010 - 9:51am
tags:
Chelsea Therapeutics, rheumatoid arthritis, FDA
Does Eli Lilly Make for an Intelligent Investment or Intelligent Speculation Today?
Seeking Alpha
Tuesday, June 29, 2010 - 9:17am
tags:
Eli Lilly
Analysts turn bearish on Roche's taspoglutide prospects
Fierce Biotech
Tuesday, June 29, 2010 - 9:17am
tags:
diabetes, taspoglutide, analysts, Roche
Halozyme says enzyme boosts insulin absorption
Yahoo/AP
Tuesday, June 29, 2010 - 9:14am
tags:
Halozyme, insulin, diabetes, enzymes
King Pharma, Pain Therapeutics change Remoxy deal
Yahoo/AP
Tuesday, June 29, 2010 - 9:13am
tags:
Pain Therapeutics, King, Remoxy, painkillers, Europe
Depomed receives $10 million milestone payment from partner Abbott Products for pain drug
Yahoo/AP
Tuesday, June 29, 2010 - 9:13am
tags:
Depomed, Abbott Laboratories, partnerships, shingles
Abbott looks to sell its flu vaccine unit: report
Reuters
Tuesday, June 29, 2010 - 9:11am
tags:
Abbott Laboratories, M&A, Flu, vaccines, Solvay
GSK backs Avandia again amid renewed pressure for withdrawal
Pharma Times, UK
Tuesday, June 29, 2010 - 9:08am
tags:
GSK, Avandia, diabetes
Why Avandia Will Change The Drug Industry
Forbes
Tuesday, June 29, 2010 - 9:07am
tags:
Avandia, GSK, diabetes
Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Bloomberg
Tuesday, June 29, 2010 - 9:05am
tags:
cancer, Effient, Eli Lilly, blood thinners, Plavix, Bristol-Myers Squibb
CSL Says Its Flu Vaccines Aren't Contaminated After U.S. FDA Issues Letter
Bloomberg
Tuesday, June 29, 2010 - 9:04am
tags:
FDA, CSL, Flu, vaccines, contamination
Teva Gets FDA OK for Generic Effexor XR
TheStreet.com
Tuesday, June 29, 2010 - 8:52am
tags:
Teva Pharmaceuticals, FDA, generics, Effexor XR, Pfizer, antidepressants
Eli Lilly: This Big Pharma Needs to Get Better
Seeking Alpha
Tuesday, June 29, 2010 - 8:51am
tags:
Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb, Humalog, Zyprexa, Cymbalta, patents, Gemzar
Cholesterol drugs for the healthy still debatable
Yahoo/AP
Tuesday, June 29, 2010 - 8:49am
tags:
cholesterol, Crestor, statins, AstraZeneca
Forest Laboratories says potential diabetic pain drug Radiprodil fails midstage study
Yahoo/AP
Monday, June 28, 2010 - 7:03pm
tags:
Forest Labs, diabetes, clinical trials, Radiprodil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.